Neotract raises $23.7M to treat urological and gynecological disorders
Neotract, maker of devices used to treat urological and gynecological disorders, has raised $23.73 million of a targeted $25.2 million second round of funding according to PE Hub. Based in Pleasanton, Calif., the company was backed in this round by Johnson & Johnson Development Corp. and New Enterprise Associates.
Life-science briefing: Thursday, April 10, 2008
TODAY’S HEADLINES:
HealthExtras buys venture-backed PBM HospiScript for $100M (release)
Urological device-maker NeoTract adds $7.4M (VentureWire)
RNAi-drug startup Intradigm seeks $35M (VentureWire)
Israel’s Arbel Medical raises $3.5M for tumor cryotherapy (release)
HealthExtras buys venture-backed PBM HospiScript for $100M — HospiScript Services, a Montgomery, Ala., prescription-benefits manager, agreed to be acquired by HealthExtras of Rockville, Md. HealthExtras will pay $100 million in cash for the venture-backed firm, which services the hospice industry.
HospiScript had raised at least $4 million in funding, according… Continue Reading
Life-science briefing: Monday, April 7, 2008
TODAY’S HEADLINES:
Quark Pharma gets $27M for RNAi drugs (release)
TargetRx takes in $9.6M for physician-prescribing data (release)
D-Pharm raises more than $3M for fat-like drugs (release)
Vortex Medical raises $2.3M for medical devices (VentureWire)
Specialty pharma Ascio takes in $3M (VentureWire)
Keraderm gets $1.7M for antifungal drugs (VentureWire)
Contract researcher CTMG raises $500K toward $1M round (VentureWire)
Singapore’s Progeniq raises seed funding for life-science computing (release)
Acrongenomics scuttles Molecular Vision acquisition (peHUB)
Michael Gutch joins H.I.G. Ventures (release)
Quark Pharma gets $27M for RNAi drugs – Fremont, Calif.-based Quark Pharmaceuticals,… Continue Reading